{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:03:00Z","timestamp":1773745380326,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.yebeh.2016.10.020","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T08:00:21Z","timestamp":1482825621000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment"],"prefix":"10.1016","volume":"66","author":[{"given":"Bernd","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.yebeh.2016.10.020_bb0005","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2016.10.020_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2016.10.020_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yebeh.2014.09.072","article-title":"Clinical experience with perampanel: focus on psychiatric adverse effects","volume":"41","author":"Coyle","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yebeh.2016.05.007","article-title":"Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: a single-center postmarketing study","volume":"61","author":"Singh","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yebeh.2015.11.002","article-title":"Prospective audit with adjunctive perampanel: preliminary observations in focal epilepsy","volume":"54","author":"Brodie","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.yebeh.2016.06.005","article-title":"Adjunctive perampanel in refractory epilepsy: experience at tertiary epilepsy care center in Tours","volume":"61","author":"Maurousset","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.yebeh.2016.10.020_bb0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eplepsyres.2014.03.015","article-title":"A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria","volume":"108","author":"Steinhoff","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2015.10.017","article-title":"Clinical experience with adjunctive perampanel in adult patients with uncontrolled epilepsy: a UK and Ireland multicentre study","volume":"34","author":"Shah","year":"2016","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2016.10.020_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1684\/epd.2016.0824","article-title":"One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability","volume":"18","author":"Garamendi-Ruiz","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2016.08.001","article-title":"Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: the FYDATA study","volume":"126","author":"Villanueva","year":"2016","journal-title":"Epilepsy Res"},{"issue":"8","key":"10.1016\/j.yebeh.2016.10.020_bb0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2788.2009.01182.x","article-title":"Consensus guidelines into the management of epilepsy in adults with an intellectual disability","volume":"53","author":"Kerr","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yebeh.2015.02.008","article-title":"A retrospective evaluation of retigabine in patients with cognitive impairment with highly drug-resistant epilepsy","volume":"44","author":"Huber","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2016.10.020_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","article-title":"The Liverpool Adverse Events Profile: relation to AED use and mood","volume":"48","author":"Panelli","year":"2007","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2016.10.020_bb0075","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1528-1167.2010.02737.x","article-title":"A graded system to categorize drug-resistant epilepsy","volume":"51","author":"Gomez-Alonso","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.10.020_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yebeh.2013.11.017","article-title":"Increased risk of suicidality on perampanel (Fycompa(R))?","volume":"31","author":"Huber","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2016.10.020_bb0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2016.10.020_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00044011-199816040-00001","article-title":"Lamotrigine in multihandicapped therapy-resistant epileptic patients","volume":"16","author":"Huber","year":"1998","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.yebeh.2016.10.020_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00115-002-1294-3","article-title":"Effects of topiramate in patients with epilepsy and intellectual deficits","volume":"73","author":"Huber","year":"2002","journal-title":"Nervenarzt"},{"issue":"3","key":"10.1016\/j.yebeh.2016.10.020_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1059-1311(03)00154-7","article-title":"Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities","volume":"13","author":"Huber","year":"2004","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2016.10.020_bb0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1059-1311(03)00101-8","article-title":"Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients","volume":"12","author":"Huber","year":"2003","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2016.10.020_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.yebeh.2008.04.021","article-title":"Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability","volume":"13","author":"Huber","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2016.10.020_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12504","article-title":"Adverse effects and safety profile of perampanel: a review of pooled data","volume":"55","author":"Rugg-Gunn","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2016.10.020_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ane.12529","article-title":"Perampanel for focal epilepsy: insights from early clinical experience","volume":"133","author":"Trinka","year":"2016","journal-title":"Acta Neurol Scand"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T08:02:03Z","timestamp":1601280123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016304103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":24,"alternative-id":["S1525505016304103"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.020","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}